Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000049

CEO bought 32,000 shares at an average $0.01 ($288)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2019-09-06 Purchase : show line 1 in the form +5,000 $0.01 $46 25,303,297 D
2019-09-06 Purchase : show line 2 in the form +5,000 $0.01 $46 25,308,297 D
2019-09-06 Purchase : show line 3 in the form +5,000 $0.01 $46 25,313,297 D
2019-09-09 Purchase : show line 4 in the form +2,000 $0.01 $20 25,315,297 D
2019-09-09 Purchase : show line 5 in the form +5,000 $0.01 $41 25,320,297 D
2019-09-09 Purchase : show line 6 in the form +2,000 $0.01 $17 25,322,297 D
2019-09-10 Purchase : show line 7 in the form +2,000 $0.01 $19 25,324,297 D
2019-09-10 Purchase : show line 8 in the form +2,000 $0.01 $19 25,326,297 D
2019-09-11 Purchase : show line 9 in the form +2,000 $0.01 $17 25,328,297 D
2019-09-11 Purchase : show line 10 in the form +2,000 $0.01 $18 25,330,297 D
Open-market purchases · 32,000 sh · avg $0.01 · $288
Loading xslF345X03/primary_doc.xml…